Methods: This is a prospective cohort study conducted in the critical care unit of a subspecialty hospital between August 2017 to January 2018 involving mechanically ventilated patients suspected with VAP. The PCT level was obtained from the qualified subjects on the day of VAP suspicion. All tests were done using enzyme-linked fluorescent assay technique. Receiver operating characteristics analysis was used to determine the diagnostic parameters of PCT. The population was divided into VAP and no-VAP group.
cant difference was observed in preoperative characteristics between the VAP and non-VAP group. The occurrence of postoperative complications (P = 0.005), duration of ICU days (P = 0.02), and mortality (P = 0.005) were statistically significant in VAP group when compared with the non-VAP group. The optimum diagnostic PCT cut-off value for VAP on the day of suspicion was 1.77 ng/mL, with a sensitivity of 74% and specificity of 86%. The areas under the ROC curve was 0.84
Conclusion:
The result suggested that PCT may be utilized as a diagnostic biomarker for pediatric VAP following cardiac surgery. Methods: We retrospectively reviewed the medical records of patients who underwent VAFTS debridement under local anaesthesia for multiloculated PE from January 2007 to December 2017. The baseline patient data, including haematology, radiologic findings, and bacterial examinations, were collected. The primary outcome was hospital mortality without additional operation under general anaesthesia. The potential predictors were analyzed for possible association with the outcomes.
Results: A total of 69 patients with multiloculated PE were treated by VAFTS debridement. Based on the Light classification, infection was staged as class 5 in 45 patients and as class 7 in 24 patients. The average onset of symptoms was 13.3 AE 13.8 days before the procedure. VAFTS debridement was successful in 59 patients (85.5%); 7 patients required subsequent operation under general anaesthesia and 3 patients died due to sepsis. Complications occurred in 3 patients (4.3%). A microbiological diagnosis could be made in 26 patients (44.1%). Multivariate logistic regression analysis revealed that leukocytosis of >15,000/μL (P = 0.016) and duration from the onset of symptoms to the procedure (P = 0.010) were independently associated with the success of this procedure.
Single-trocar VAFTS debridement can be an acceptable first choice of treatment in patients with multiloculated PE. Importantly, this procedure should be performed as early as possible for a successful outcome and to obtain useful information on the nature of the pleural effusion and the status of the pleural cavity. Background and Aims: Pneumonia is a significant contributor to morbidity and mortality. Current Australian treatment guidelines on community-acquired pneumonia recommend performing blood cultures on all hospitalised patients and urinary antigen testing in severe disease, based on the SMART-COP or CORB severity scores. However, diagnostic yield for aetiology remains low.
The availability of urinary antigen testing for S. pneumoniae and Legionella pneumophilia has enabled rapid aetiological diagnosis and directed antibiotic therapy. There is conflicting data on the clinical utility of pneumococcal and legionella urinary antigen testing and its impact on antibiotic prescribing in community-acquired pneumonia. 
